Summary of information on human CYP enzymes: human P450 metabolism data.
about
Drug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An OverviewBiology of PXR: role in drug-hormone interactionsSMARTCyp: A 2D Method for Prediction of Cytochrome P450-Mediated Drug MetabolismAn open conformation of mammalian cytochrome P450 2B4 at 1.6-A resolutionStructural and Thermodynamic Consequences of 1-(4-Chlorophenyl)imidazole Binding to Cytochrome P450 2B4 † , ‡Human Cytochrome P450 1A1 Structure and Utility in Understanding Drug and Xenobiotic MetabolismPrediction-driven matched molecular pairs to interpret QSARs and aid the molecular optimization processInsights into CYP2B6-mediated drug-drug interactionsSedation in Critically Ill Children with Respiratory FailureQSAR modeling: where have you been? Where are you going to?Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug responseFunctionally defective or altered CYP3A4 and CYP3A5 single nucleotide polymorphisms and their detection with genotyping testsMetabolic activity and mRNA levels of human cardiac CYP450s involved in drug metabolismEvaluation of influence of single nucleotide polymorphisms in cytochrome P450 2B6 on substrate recognition using computational docking and molecular dynamics simulationUnderstanding a substrate's product regioselectivity in a family of enzymes: a case study of acetaminophen binding in cytochrome P450sLinear Interaction Energy Based Prediction of Cytochrome P450 1A2 Binding Affinities with Reliability EstimationChronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time courseComputational tools and resources for metabolism-related property predictions. 1. Overview of publicly available (free and commercial) databases and softwareModulation of the rat hepatic cytochrome P4501A subfamily using biotin supplementationGenetic variability in CYP3A5 and its possible consequences.Contributions of human enzymes in carcinogen metabolismRS-Predictor models augmented with SMARTCyp reactivities: robust metabolic regioselectivity predictions for nine CYP isozymes.Selecting Relevant Descriptors for Classification by Bayesian Estimates: A Comparison with Decision Trees and Support Vector Machines Approaches for Disparate Data Sets.Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.Pharmacokinetic interactions of drugs with St John's wort.Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries.Summary of information on the effects of ionizing and non-ionizing radiation on cytochrome P450 and other drug metabolizing enzymes and transporters.Targeting protein kinases in central nervous system disordersThe associations of genetic polymorphisms in CYP1A2 and CYP3A4 with clinical outcomes of breast cancer patients in northern China.Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and responseA haplotype of CYP2C9 associated with warfarin sensitivity in mechanical heart valve replacement patients.Bioavailability challenges associated with development of anti-cancer phenolics.Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse.Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.Improved cytochrome P450 3A4 molecular models accurately predict the Phe215 requirement for raloxifene dehydrogenation selectivity.A quantitative high-throughput 96-well plate fluorescence assay for mechanism-based inactivators of cytochromes P450 exemplified using CYP2B6.Inhibition of cytochrome p450 enzymes by the e- and z-isomers of norendoxifen.The inhibitory activity of the extracts of popular medicinal herbs on CYP1A2, 2C9, 2C19 and 3A4 and the implications for herb-drug interaction.CYP2A13 genetic polymorphism in French Caucasian, Gabonese and Tunisian populations.Which sources of flavonoids: complex diets or dietary supplements?
P2860
Q26767516-1ADA6B0B-0B44-4006-9462-B95109E0C537Q26822721-2BC5C8A5-5540-4C33-9592-1A1944161104Q27136650-AAEA9812-741B-4451-9BE5-21B427B0F76EQ27642370-DECCD4CC-1A31-484E-9E32-B72D629C521EQ27648413-B0BBBD82-A5D5-4E81-9880-ADEEC3FB54DAQ27676875-68B82EED-AB61-4DF4-AA89-A4246671751FQ27902343-24898C5C-440A-4852-BB34-723886FBE547Q28078857-73230474-0D28-47C3-A152-7309839636E9Q28080112-2B269CC7-56E5-490A-9C71-FE5169E43431Q28222668-513D6EAD-B230-4A45-96D8-3F07C97669CCQ28252209-6DEA9574-BBA3-44B5-A143-6442FD9742E6Q28260518-9FEF0E66-64C7-452E-8255-6B26C18C4B77Q28476513-C2795466-FD02-4099-A746-FD0414FF5DD1Q28538496-8848DEA3-07CE-4822-9094-6EFF3CAA710BQ28539428-FE3F8CCF-BC13-430A-804A-407EC754BE40Q28550779-A9655DC1-84FA-41AE-B551-BCC2480A7C74Q28578348-639BC144-ED1C-4AED-9219-2E7144426C66Q28659783-4A642028-F3FE-4AE1-BE9F-91EAED78E77DQ28681868-B044720A-B20A-4E84-A724-34CD50A51A44Q30341330-60FB3CF3-93B1-4261-9A84-F804A3A9C0AFQ30520640-83385524-8F8E-4CF2-B7D8-CCF1C1EB5C02Q30525178-3336AB63-56C8-410E-8768-C5C64EB69319Q31118093-6DCCAC08-378B-4F9D-A537-9C7F3BD6EA54Q31144283-7DF687AC-2113-42E6-A73D-6385E54E269DQ33204911-88334327-A02E-421D-9D77-8459B208955AQ33512310-F08153AB-B4B9-4085-BD17-85D49B93F175Q33557244-B692B1A2-A6C8-418E-A4DA-1C6411CDE6AEQ33671660-D6E5A121-5EC9-4EA5-AB9A-13E321E76D79Q33888802-49B23B57-D982-4093-B8D2-69C602022703Q33903933-09E2FB23-E266-4F9A-ADAB-14E4D0ECCF82Q34026245-B7CE9847-2BF1-4873-9535-40D4E3ACF77DQ34057398-067619E1-4171-47CE-B00E-43050B7BE0EBQ34165511-3F66F72F-0DA8-4B7E-B64F-F4CE09D7C75DQ34204238-6891ACF2-B9FD-4896-BC32-D6094F4C0568Q34219097-3B513E0F-4A24-47FB-9A1F-F2E7827D1E55Q34256839-74A2058A-9FD2-4BA6-B930-44C0868365BFQ34355283-6006ADD5-5879-4DC1-A55F-EB4F709D8B02Q34367117-0CE01DDC-AF5D-4B7E-9EFE-0242E28E8927Q34471338-028AA5F5-23DA-40CD-B146-C7D49B06322FQ34591974-8C53A01E-C1BB-43FD-A506-B9653567C0B1
P2860
Summary of information on human CYP enzymes: human P450 metabolism data.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Summary of information on human CYP enzymes: human P450 metabolism data.
@ast
Summary of information on human CYP enzymes: human P450 metabolism data.
@en
type
label
Summary of information on human CYP enzymes: human P450 metabolism data.
@ast
Summary of information on human CYP enzymes: human P450 metabolism data.
@en
prefLabel
Summary of information on human CYP enzymes: human P450 metabolism data.
@ast
Summary of information on human CYP enzymes: human P450 metabolism data.
@en
P2860
P356
P1476
Summary of information on human CYP enzymes: human P450 metabolism data.
@en
P2093
Slobodan Rendic
P2860
P304
P356
10.1081/DMR-120001392
P407
P577
2002-02-01T00:00:00Z